TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,000 | -67.5% | 10,663 | -4.7% | 0.00% | -100.0% |
| Q2 2023 | $277,000 | +33.8% | 11,186 | -18.5% | 0.00% | – |
| Q1 2023 | $207,000 | +14.4% | 13,725 | -10.3% | 0.00% | – |
| Q4 2022 | $181,000 | +84.7% | 15,302 | -7.4% | 0.00% | – |
| Q3 2022 | $98,000 | +42.0% | 16,528 | -0.5% | 0.00% | – |
| Q2 2022 | $69,000 | -46.5% | 16,603 | +22.1% | 0.00% | – |
| Q1 2022 | $129,000 | -36.1% | 13,603 | +28.3% | 0.00% | – |
| Q4 2021 | $202,000 | -71.2% | 10,605 | -49.7% | 0.00% | -100.0% |
| Q3 2021 | $701,000 | -14.7% | 21,084 | -0.4% | 0.00% | 0.0% |
| Q2 2021 | $822,000 | +7.0% | 21,169 | +32.8% | 0.00% | 0.0% |
| Q1 2021 | $768,000 | -1.5% | 15,944 | +7.0% | 0.00% | -33.3% |
| Q4 2020 | $780,000 | +80.1% | 14,903 | -7.9% | 0.00% | +50.0% |
| Q3 2020 | $433,000 | +25.5% | 16,175 | -8.6% | 0.00% | 0.0% |
| Q2 2020 | $345,000 | +92.7% | 17,699 | -2.7% | 0.00% | +100.0% |
| Q1 2020 | $179,000 | -71.6% | 18,199 | -67.8% | 0.00% | -75.0% |
| Q4 2019 | $631,000 | +557.3% | 56,482 | +230.3% | 0.00% | +300.0% |
| Q3 2019 | $96,000 | -24.4% | 17,100 | +17.1% | 0.00% | 0.0% |
| Q2 2019 | $127,000 | -6.6% | 14,600 | -19.3% | 0.00% | 0.0% |
| Q1 2019 | $136,000 | +103.0% | 18,100 | +5.8% | 0.00% | 0.0% |
| Q4 2018 | $67,000 | -22.1% | 17,100 | +4.6% | 0.00% | 0.0% |
| Q3 2018 | $86,000 | -54.5% | 16,350 | +13.5% | 0.00% | 0.0% |
| Q2 2018 | $189,000 | -7.4% | 14,400 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $204,000 | +119.4% | 14,400 | +26.3% | 0.00% | +100.0% |
| Q4 2017 | $93,000 | -29.5% | 11,400 | +2.7% | 0.00% | 0.0% |
| Q3 2017 | $132,000 | +15.8% | 11,100 | -2.6% | 0.00% | 0.0% |
| Q2 2017 | $114,000 | -32.9% | 11,400 | -25.5% | 0.00% | -50.0% |
| Q1 2017 | $170,000 | – | 15,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |